32 min listen
Medicare Coverage of Aducanumab
ratings:
Length:
18 minutes
Released:
Jan 31, 2022
Format:
Podcast episode
Description
Dr. Jason Crowell talks with Pulitzer Prize-winning New York Times journalist Pam Belluck about the impact of Medicare’s decision to limit patient access to aducanumab for the treatment of Alzheimer disease, restricting use to individuals in clinical trials.
Released:
Jan 31, 2022
Format:
Podcast episode
Titles in the series (100)
November 13 2007 Issue: A midlife stroke surge among women in the United States by Neurology® Podcast